UNVEILING GREY MATTER CHANGES
Addressing the neurochemical variations and brain abnormalities linked to schizophrenia. The objective of this study is to look at the association between neurotransmitter pathways, antipsychotic medication, and grey matter shrinkage in schizophrenia patients.A structural MRI investigation was done on 28 schizophrenia patients and an equal number of healthy subjects. Emphasizing on four key neurotransmitters (dopamine, serotonin, glutamate, and GABA) and their relationships to antipsychotic drugs, and grey matter changes. In comparison to healthy participants, our findings demonstrated significant grey matter degeneration in schizophrenia patients.
- The potential of buckwheat as neglected plants
- Catalytic valorisation of agro-forestry biomass wastes to ethylene glycol
- Effect of Different Base Design, Resin Material and Prosthesis Types on the Trueness of 3D-Printed Dental Casts
- New generation B-lactam/B-lactamase inhibitors: Taniborbactam
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.Get Started
Ask a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.Get Started